SDC1 and Miyoshi myopathy: Indeed, CRISPR/Cas9-mediated deletion of Syndecan-1 heparan sulfate side chains inhibits Wnt-signaling activity and reduces the growth of MM cell lines suggesting autonomous Wnt-signaling stimulation via the autocrine release of Wnts (45).